SARS-CoV-2 Associated Coagulopathy And Thromboembolism Prophylaxis In Children: A Single Centre Observational Study.

CONCLUSIONS: COVID-19 pediatric patients show mildly altered coagulation and inflammatory parameters; on the other hand, MIS-C cases show laboratory signs of an inflammatory driven pro-coagulant status. Universal anticoagulant prophylaxis in hospitalised children with SARS-CoV-2 related manifestations is not warranted, but may be offered to patients with other pro-thrombotic risk factors in the context of a multi-modal therapeutic approach.
PMID: 33305475 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - December 11, 2020 Category: Hematology Authors: Del Borrello G, Giraudo I, Bondone C, Denina M, Garazzino S, Linari C, Mignone F, Pruccoli G, Scolfaro C, Spadea M, Pollio B, Saracco P Tags: J Thromb Haemost Source Type: research